semaglutide type 1 diabetes randomized trial 2024 2 drug improves weight loss, blood sugar in certain Type patients with obesity Live Updates on Semaglutide's Current
Description
Very low LDL (below 50-70 mg/dL) achieved through aggressive medication raises theoretical concerns about reduced hormone production, potential cognitive effects, and increased hemorrhagic stroke risk in some populations

The mesh is prone to migrating, which can cause adhesion, organ perforation, infection, and bowel obstruction

Others come to us after weight loss to address excess skin or stubborn fat

Proteins Eating protein while losing weight is essential to support your brain health and avoid muscle loss (and Ozempic face)

If GLP-1 medications reduce oral progesterone absorption, the endometrial protection could be compromised

So far, clinical trials have not found strong evidence of mood-related side effects in most users
